The tariff classification of Fosaprepitant Dimeglumine Injection in dosage form, from India
Issued August 28, 2019 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9260
Headings: 3004
Product description
Fosaprepitant Dimeglumine Injection, imported in 150 mg single dose vials, is an antiemetic drug. It is indicated for use with other medications to prevent nausea and vomiting caused by cancer treatment (chemotherapy).
CBP rationale
The applicable subheading for the Fosaprepitant Dimeglumine Injection in dosage form will be 3004.90.9260, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the digestive system: Other.
Full text
N305645 August 28, 2019 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9260 Ms. Tanya Hurley BluePoint Laboratories Eastgate Business Park 8 Eastgate Avenue Little Island, Cork Ireland RE: The tariff classification of Fosaprepitant Dimeglumine Injection in dosage form, from India Dear Ms. Hurley: In your letter dated August 6, 2019, you requested a tariff classification ruling. Fosaprepitant Dimeglumine Injection, imported in 150 mg single dose vials, is an antiemetic drug. It is indicated for use with other medications to prevent nausea and vomiting caused by cancer treatment (chemotherapy). The applicable subheading for the Fosaprepitant Dimeglumine Injection in dosage form will be 3004.90.9260, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the digestive system: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Balsalazide Disodium Capsules USP and Carbidopa Tablets in dosage form, from Taiwan and India, respectively
The tariff classification of Loperamide Hydrochloride Capsules, USP and Methylene Blue Injection, USP in dosage form, from India and Italy, respectively
The tariff classification of Pantoprazole Sodium for Injection in dosage form, from India
The tariff classification of Fesoterodine Fumarate Extended-Release Tablets, Famotidine Tablets and Lenalidomide Capsules, in dosage form, from India
The tariff classification of Lansoprazole Delayed-Release Orally Disintegrating Tablets in dosage form, from India
The tariff classification of Famotidine Suspension in dosage form, from India
The tariff classification of Mesalamine Suppositories in dosage form, from Italy
The tariff classification and country of origin of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, 5 mg/2.5 mg
The tariff classification of Ondansetron Tablets in dosage form, from India
The tariff classification of Desvenlafaxine Extended Release Tablets and Mesalamine Extended Release Capsules from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →